UAB "PharmaSwiss" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statement report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2020 |
---|
9,843,906 |
511,106 |
387,519 |
276,748 |
14,369 |
39.90 |
2.81 |
3,137,024 |
979,294 |
155,997 |
4,617,694 |
2021 |
---|
10,063,266 |
557,213 |
-454,900 |
-561,269 |
-31,078 |
35.51 |
-5.58 |
1,975,755 |
2,105,923 |
0 |
4,163,786 |
2022 |
---|
1,241,210 |
273,394 |
1,076,076 |
989,337 |
217,916 |
100.00 |
79.71 |
2,965,092 |
0 |
0 |
2,965,092 |
Register and
explore Okredo dataRegister and
explore Okredo data2022
Turnover (€)
1,241,210 €-88 % *
Sales per employee (€)
273,394 €-51 % *
Profit before tax (€)
1,076,076 €337 % *
Net Profit (€)
989,337 €276 % *
Profit per employee (€)
217,916 €801 % *
Total profitability (%)
100.00 %181.61 % *
Net profitability (%)
79.71 %1,528.49 % *
Equity (€)
2,965,092 €50 % *
Amounts Payable And Liabilities (€)
0 €-100 % *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
2,965,092 €-29 % *